4
Changes in Ownership
Armata Pharmaceuticals, Inc. Filed Acc 0001104659-25-010561
Options or other derivatives
- Chief Business Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kyme Pierre Chief Business Officer | 2025-02-05 | Grant or award · Stock Options (Right to Buy) | +100,000 | 100,000 | D: show line 1 in the form |
Loading xslF345X05/tm255864-5_4seq1.xml…